These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 10724301)
21. Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients. Cuvelier A; Muir JF; Benhamou D; Weitzenblum E; Zuck P; Delacenserie R; Taytard A; Iacono P Respir Care; 2002 Feb; 47(2):159-66. PubMed ID: 11812272 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of a novel beclomethasone dipropionate dry powder inhaler (Clickhaler) for the treatment of adult asthma. Amsterdam Clinical Study Group. Stradling JR; Pearson MG; Morice AH; Peake MD; Barnes NC J Asthma; 2000 Apr; 37(2):183-90. PubMed ID: 10805207 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. Zuwallack R; De Salvo MC; Kaelin T; Bateman ED; Park CS; Abrahams R; Fakih F; Sachs P; Pudi K; Zhao Y; Wood CC; Respir Med; 2010 Aug; 104(8):1179-88. PubMed ID: 20172704 [TBL] [Abstract][Full Text] [Related]
24. Lung delivery of salbutamol given by breath activated pressurized aerosol and dry powder inhaler devices. Lipworth BJ; Clark DJ Pulm Pharmacol Ther; 1997 Aug; 10(4):211-4. PubMed ID: 9695144 [TBL] [Abstract][Full Text] [Related]
25. Comparison of powder and aerosol formulations of salmeterol in the treatment of asthma. Wolfe J; Kreitzer S; Chervinsky P; Lawrence M; Wang Y; Reilly D; Davis S; Stahl E Ann Allergy Asthma Immunol; 2000 Mar; 84(3):334-40. PubMed ID: 10752919 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the bronchodilating efficacies of a novel salbutamol metered dose powder inhaler and a pressurised metered dose aerosol with a spacer. Seppälä OP; Kari E; Elo J; Löyttyniemi E; Kunkel G Arzneimittelforschung; 1998 Sep; 48(9):919-23. PubMed ID: 9793619 [TBL] [Abstract][Full Text] [Related]
27. Comparative efficacy and safety of albuterol sulfate Spiros inhaler and albuterol metered-dose inhaler in asthma. Nelson H; Kemp JP; Bieler S; Vaughan LM; Hill MR Chest; 1999 Feb; 115(2):329-35. PubMed ID: 10027428 [TBL] [Abstract][Full Text] [Related]
28. Albuterol delivered by metered-dose inhaler (MDI), MDI with spacer, and Rotahaler device--a comparison of efficacy and safety. Golish J; Curtis-McCarthy P; McCarthy K; Kavuru M; Wagner W; Beck G; Eng P J Asthma; 1998; 35(4):373-9. PubMed ID: 9669832 [TBL] [Abstract][Full Text] [Related]
29. The role of domiciliary nebulizers in managing patients with severe COPD. Eiser N; Angus K; McHale S Respir Med; 2001 Apr; 95(4):265-74. PubMed ID: 11316108 [TBL] [Abstract][Full Text] [Related]
30. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing. Deerojanawong J; Manuyakorn W; Prapphal N; Harnruthakorn C; Sritippayawan S; Samransamruajkit R Pediatr Pulmonol; 2005 May; 39(5):466-72. PubMed ID: 15786440 [TBL] [Abstract][Full Text] [Related]
31. Easyhaler, a novel multiple dose powder inhaler: clinically equivalent to salbutamol metered dose inhaler and easier to use. Nieminen MM; Vidgren M; Laurikainen K; Järvinen M; Liippo K; Tammivaara R; Silvasti M Respiration; 1994; 61(1):37-41. PubMed ID: 8177971 [TBL] [Abstract][Full Text] [Related]
32. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients. Dusser D; Vicaut E; Lefrançois G; Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009 [TBL] [Abstract][Full Text] [Related]
34. The efficacy of a new salbutamol metered-dose powder inhaler in comparison with two other inhaler devices. Seppälä OR; Aalto E; Annila ; Hakonen T; Lukkari-Lax E; Jouhikainen T; Nieminen MM; Liipp K Respir Med; 2001 Dec; 95(12):949-53. PubMed ID: 11778791 [TBL] [Abstract][Full Text] [Related]
35. Bronchodilation of formoterol administered with budesonide: device and formulation effects. Miller CJ; Senn S; Mezzanotte WS Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985 [TBL] [Abstract][Full Text] [Related]
37. Bronchodilator responsiveness in children with asthma is not influenced by spacer device selection. D'Vaz N; Okitika TA; Shackleton C; Devadason SG; Hall GL Pediatr Pulmonol; 2019 May; 54(5):531-536. PubMed ID: 30719873 [TBL] [Abstract][Full Text] [Related]
38. Efficacy of salbutamol via Easyhaler unaffected by low inspiratory flow. Koskela T; Malmström K; Sairanen U; Peltola S; Keski-Karhu J; Silvasti M Respir Med; 2000 Dec; 94(12):1229-33. PubMed ID: 11192960 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405 [TBL] [Abstract][Full Text] [Related]
40. Metered dose inhaler with spacer versus dry powder inhaler for delivery of salbutamol in acute exacerbations of asthma: a randomized controlled trial. Lodha R; Gupta G; Baruah BP; Nagpal R; Kabra SK Indian Pediatr; 2004 Jan; 41(1):15-20. PubMed ID: 14767083 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]